Inhibition of Thymocyte Apoptosis and Negative Antigenic Selection in Bcl-2 Transgenic Mice

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Aug 1

PMID 1495993

Citations 33

Authors

R M Siegel

M Katsumata

T Miyashita

D C Louie

M I Greene

J C Reed

Affiliations

Soon will be listed here.

Abstract

The bcl-2 gene, which is overexpressed in human follicular B-cell lymphomas, has been found to extend cellular lifespan through inhibition of apoptosis, or programmed cell death. However, the physiological role of the Bcl-2 protein in lymphocyte development is unclear. We have established a transgenic mouse line that expresses high levels of the Bcl-2 protein in both cortical and medullary thymocytes, disrupting the normal pattern of expression of this gene. We found that in these mice, immature thymocytes became resistant to apoptosis mediated by corticosteroids and calcium ionophores. Untreated thymocytes also exhibited a survival advantage in suspension cultures compared with controls. In addition, overexpression of bcl-2 enabled a proportion of thymocytes and peripheral T cells to escape the process of clonal deletion, which normally eliminates self-reactive T cells during thymocyte maturation. These findings implicate the Bcl-2 protein in regulating the lifespan of maturing thymocytes and in the antigenic-selection process.

Citing Articles

STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of and following glucocorticoid treatment.

Van der Zwet J, Cordo V, Buijs-Gladdines J, Hagelaar R, Smits W, Vroegindeweij E Haematologica. 2022; 108(3):732-746.

PMID: 35734930 PMC: 9973477. DOI: 10.3324/haematol.2021.280405.

Creating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP Receptors.

Distelhorst C, Bootman M Cold Spring Harb Perspect Biol. 2019; 11(9).

PMID: 31110129 PMC: 6719601. DOI: 10.1101/cshperspect.a035196.

Targeting Bcl-2-IP receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones.

Distelhorst C Biochim Biophys Acta Mol Cell Res. 2018; 1865(11 Pt B):1795-1804.

PMID: 30053503 PMC: 6345611. DOI: 10.1016/j.bbamcr.2018.07.020.

Effects of Systemically Administered Hydrocortisone on the Human Immunome.

Olnes M, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R Sci Rep. 2016; 6:23002.

PMID: 26972611 PMC: 4789739. DOI: 10.1038/srep23002.

T cell-specific inhibition of multiple apoptotic pathways blocks negative selection and causes autoimmunity.

Burger M, Leung K, Bennett M, Winoto A Elife. 2014; 3.

PMID: 25182415 PMC: 4171708. DOI: 10.7554/eLife.03468.

References

McDonnell T, Nunez G, Platt F, Hockenberry D, London L, McKearn J . Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol. 1990; 10(5):1901-7. PMC: 360535. DOI: 10.1128/mcb.10.5.1901-1907.1990. View

Guidos C, Danska J, Fathman C, Weissman I . T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med. 1990; 172(3):835-45. PMC: 2188558. DOI: 10.1084/jem.172.3.835. View

Hockenbery D, Nunez G, Milliman C, Schreiber R, Korsmeyer S . Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990; 348(6299):334-6. DOI: 10.1038/348334a0. View

Yui K, Komori S, Katsumata M, Siegel R, Greene M . Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice. Proc Natl Acad Sci U S A. 1990; 87(18):7135-9. PMC: 54698. DOI: 10.1073/pnas.87.18.7135. View

Smith C, Williams G, Kingston R, Jenkinson E, Owen J . Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 1989; 337(6203):181-4. DOI: 10.1038/337181a0. View

McConkey D, Nicotera P, Hartzell P, Bellomo G, Wyllie A, Orrenius S . Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys. 1989; 269(1):365-70. DOI: 10.1016/0003-9861(89)90119-7. View

Brombacher F, Lamers M, Kohler G, Eibel H . Elimination of CD8+ thymocytes in transgenic mice expressing an anti-Lyt2.2 immunoglobulin heavy chain gene. EMBO J. 1989; 8(12):3719-26. PMC: 402055. DOI: 10.1002/j.1460-2075.1989.tb08547.x. View

Yunis J, Mayer M, Arnesen M, Aeppli D, Oken M, Frizzera G . bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med. 1989; 320(16):1047-54. DOI: 10.1056/NEJM198904203201605. View

McDonnell T, Deane N, Platt F, Nunez G, Jaeger U, McKearn J . bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989; 57(1):79-88. DOI: 10.1016/0092-8674(89)90174-8. View

10.

Finkel T, Cambier J, Kubo R, Born W, Marrack P, Kappler J . The thymus has two functionally distinct populations of immature alpha beta + T cells: one population is deleted by ligation of alpha beta TCR. Cell. 1989; 58(6):1047-54. DOI: 10.1016/0092-8674(89)90503-5. View

11.

Cleary M, Smith S, Sklar J . Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986; 47(1):19-28. DOI: 10.1016/0092-8674(86)90362-4. View

12.

van Vliet E, Melis M, van Ewijk W . The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: a flowcytometric and immunohistological analysis. Cell Immunol. 1986; 103(2):229-40. DOI: 10.1016/0008-8749(86)90086-9. View

13.

Havran W, Poenie M, Kimura J, Tsien R, Weiss A, Allison J . Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature. 1987; 330(6144):170-3. DOI: 10.1038/330170a0. View

14.

STORB U . Transgenic mice with immunoglobulin genes. Annu Rev Immunol. 1987; 5:151-74. DOI: 10.1146/annurev.iy.05.040187.001055. View

15.

Kappler J, Staerz U, White J, Marrack P . Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988; 332(6159):35-40. DOI: 10.1038/332035a0. View

16.

MacDonald H, Schneider R, Lees R, Howe R, Acha-Orbea H, Festenstein H . T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 1988; 332(6159):40-5. DOI: 10.1038/332040a0. View

17.

Vaux D, Cory S, Adams J . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988; 335(6189):440-2. DOI: 10.1038/335440a0. View

18.

Hengartner H, Odermatt B, Schneider R, Schreyer M, Walle G, MacDonald H . Deletion of self-reactive T cells before entry into the thymus medulla. Nature. 1988; 336(6197):388-90. DOI: 10.1038/336388a0. View

19.

Kappler J, Wade T, White J, KUSHNIR E, Blackman M, Bill J . A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product. Cell. 1987; 49(2):263-71. DOI: 10.1016/0092-8674(87)90567-8. View

20.

Kappler J, Roehm N, Marrack P . T cell tolerance by clonal elimination in the thymus. Cell. 1987; 49(2):273-80. DOI: 10.1016/0092-8674(87)90568-x. View